XML 71 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
Employee Benefit Plans (Details)
12 Months Ended
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]      
Common Shares Available for Grant 17,300,000    
Federal income tax (expense) / benefit recognized from stock-based compensation | $ $ 32,000,000    
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | $   $ 29,357,000 $ 26,058,000
Performance Units and Performance Stock [Abstract]      
Compensation expense related to the company's stock-based compensation plans | $ 133,849,000 128,090,000 130,577,000
Stock Options and Sars [Member]      
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]      
Stock-based compensation expense related to stock options, SAR and ESPP grants | $ $ 56,000,000 $ 57,000,000 $ 56,000,000
Maximum term of stock options and SARs granted 7 years    
Weighted Average Fair Value And Valuation Assumptions Used To Value Stock Options/SARs, ESPP, and Performance Units/Stock-Based Compensation [Abstract]      
Weighted Average Fair Value of Grants (price per share) | $ / shares $ 23.95 $ 25.78 $ 21.88
Expected Volatility (in hundredths) 28.28% 31.54% 38.03%
Risk-Free Interest Rate (in hundredths) 1.52% 0.78% 0.83%
Dividend Yield (in hundredths) 0.75% 0.76% 0.85%
Expected Life (in years) 5 years 1 month 6 days 5 years 4 months 24 days 5 years 3 months 18 days
Stock Options and SARs Rollforward [Abstract]      
Outstanding at January 1 (in shares) 9,850,000 10,744,000 10,493,000
Granted (in shares) 2,274,000 1,855,000 2,037,000
Exercised (1) (in shares) [1] (2,574,000) (2,376,000) (1,518,000)
Forfeited (in shares) (447,000) (373,000) (268,000)
Outstanding at December 31 (in shares) 9,103,000 9,850,000 10,744,000
Stock Options/SARs Exercisable at December 31 (in shares) 4,510,000 5,613,000 5,993,000
Stock Options/SARs Exercisable at December 31 (in dollars per share) | $ / shares $ 75.76 $ 66.48 $ 57.96
Intrinsic value of stock options/SARs exercised during the period | $ $ 95,000,000 $ 84,000,000 $ 60,000,000
Stock Options/SARs Vested or Expected to Vest (in shares) 8,700,000    
Weighted average grant price for stock options/SARs vested or expected to vest (per share) | $ / shares $ 83.56    
Intrinsic value of stock options/SARs vested or expected to vest | $ $ 213,000,000    
Weighted Average Remaining Contractual Life for Stock Options/SARs Vested or Expected to Vest 4 years 3 months 18 days    
Weighted Average Grant Price Stock Option and SARs [Rollfoward]      
Outstanding at January 1 (in dollars per share) | $ / shares $ 75.53 $ 67.98 $ 64.96
Exercised (in dollars per share) | $ / shares [1] 61.12 54.56 47.64
Granted (in dollars per share) | $ / shares 96.27 94.82 69.99
Forfeited (in dollars per share) | $ / shares 93.84 87.38 80.31
Outstanding at December 31 (in dollars per share) | $ / shares $ 83.89 75.53 67.98
Performance Units and Performance Stock [Abstract]      
Unrecognized compensation expense | $ $ 98,000,000    
Weighted average period over which unrecognized compensation expense will be recognized 2 years 4 months 24 days    
Summary Information By Grant Price Range For Stock Options And SARs Outstanding And Exercisable At End Of Period [Line Items]      
Stock Options and SARs Outstanding 9,103,000    
Weighted Average Remaining Life for Outstanding Options and SARs 4 years    
Weighted Average Grant Price For Outstanding Options and SARs | $ / shares $ 83.89    
Aggregate Intrinsic Value For Outstanding Options and SARs | $ [2] $ 218,696    
Stock Options and SARs Exercisable 4,510,000    
Weighted Average Remaining Life For Exercisable Units 3 years    
Weighted Average Grant Price For Exercisable Options and SARs | $ / shares $ 75.76    
Aggregate Intrinsic Value For Exercisable Units | $ [2] $ 145,024    
ESPP [Member]      
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]      
Common Shares Available for Grant 176,000    
Percentage of fair market value at which employees may purchase company stock via the ESPP 85.00%    
Maximum Percentage Of Employee Pay Eligible For Contribution To ESPP Percentage 10.00%    
Weighted Average Fair Value And Valuation Assumptions Used To Value Stock Options/SARs, ESPP, and Performance Units/Stock-Based Compensation [Abstract]      
Weighted Average Fair Value of Grants (price per share) | $ / shares $ 22.20 $ 19.21 $ 21.21
Expected Volatility (in hundredths) 27.12% 36.55% 32.08%
Risk-Free Interest Rate (in hundredths) 0.88% 0.44% 0.12%
Dividend Yield (in hundredths) 0.71% 0.82% 0.73%
Expected Life (in years) 6 months 6 months 6 months
Stock Options and SARs Rollforward [Abstract]      
Approximate Number of Participants 1,870 1,746 1,963
Shares Purchased 180,000 212,000 225,000
Aggregate Purchase Price | $ $ 13,997,000 $ 13,787,000 $ 15,045,000
Restricted Stock and Restricted Stock Units [Member]      
Number of Shares and Units [Roll Forward]      
Outstanding at January 1 (in shares) 3,962,000 [3] 4,908,000 [3] 5,394,000
Granted (in shares) 1,095,000 853,000 1,044,000
Released (in shares) [4] (929,000) (1,465,000) (1,331,000)
Forfeited (in shares) (223,000) (334,000) (199,000)
Outstanding at December 31 (in shares) [3] 3,905,000 3,962,000 4,908,000
Weighted Average Grant Fair Value [Abstract]      
Outstanding at January 1 (in dollars per share) | $ / shares $ 79.63 [3] $ 70.35 [3] $ 64.39
Granted (in dollars per share) | $ / shares 97.34 88.01 77.94
Released (in dollars per share) | $ / shares [4] 61.51 53.95 51.52
Forfeited (in dollars per share) | $ / shares 85.45 77.29 74.56
Outstanding at December 31 (in dollars per share) | $ / shares [3] $ 88.57 $ 79.63 $ 70.35
Performance Units and Performance Stock [Abstract]      
Unrecognized compensation expense | $ $ 173,000,000    
Weighted average period over which unrecognized compensation expense will be recognized 2 years 4 months 24 days    
Share Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | $ $ 68,000,000 $ 60,000,000 $ 69,000,000
Intrinsic value released during the year | $ 91,000,000 124,000,000 109,000,000
Aggregate intrinsic value of stock and unit outstanding | $ $ 421,000,000 $ 401,000,000 $ 347,000,000
Performance Units and Performance Stock [Member]      
Weighted Average Fair Value And Valuation Assumptions Used To Value Stock Options/SARs, ESPP, and Performance Units/Stock-Based Compensation [Abstract]      
Weighted Average Fair Value of Grants (price per share) | $ / shares $ 113.81 $ 119.10 $ 80.64
Expected Volatility (in hundredths) 32.19% 32.48% 29.35%
Risk-Free Interest Rate (in hundredths) 1.60% 1.15% 1.07%
Number of Shares and Units [Roll Forward]      
Outstanding at January 1 (in shares) 545,290 [5] 405,000 [5] 333,000
Granted (in shares) 78,527 132,000 72,000
Granted for Performance Multiple (1) (in shares) 118,834 143,000 [6] 0 [6]
Released (in shares) 240,320 134,000 [7] 0 [7]
Forfeited (in shares) 0 0 0
Outstanding at December 31 (in shares) 502,331 545,290 [5] 405,000 [5]
Weighted Average Grant Fair Value [Abstract]      
Outstanding at January 1 (in dollars per share) | $ / shares $ 80.92 [5] $ 74.93 [5] $ 76.11
Granted (in dollars per share) | $ / shares 96.29 100.95 69.43
Granted for Performance Multiple (1) (in dollars per share) | $ / shares [6] 84.43 56.21 0.00
Released (in dollars per share) | $ / shares [7] 66.69 56.21 0.00
Forfeited (in dollars per share) | $ / shares 0.00 0.00 0.00
Outstanding at December 31 (in dollars per share) | $ / shares [5] $ 90.96 $ 80.92 $ 74.93
Performance Units and Performance Stock [Abstract]      
Minimum Performance Multiple at the Completion Performance Period 0.00%    
Maximum Performance Multiple at the Completion Performance Period 200.00%    
Term of Zero-Coupon Risk-Free Interest Rate Derived from the Treasury Constant Maturities Yield Curve 3 years 3 months 7 days    
Minimum Performance Units and Stock Allowed to be Outstanding 148,444    
Maximum Performance Units and Stock Allowed to be Outstanding 856,218    
Additional Performance Awards Granted 71,805    
Compensation expense related to the company's stock-based compensation plans | $ $ 10,000,000 $ 11,000,000 $ 5,000,000
Unrecognized compensation expense | $ $ 8,300,000    
Weighted average period over which unrecognized compensation expense will be recognized 2 years    
Performance Period 3 years    
Intrinsic value released during the year | $ $ 24,000,000 10,000,000 0
Aggregate intrinsic value of stock and unit outstanding | $ 54,000,000 55,000,000 29,000,000
Lease And Well [Member]      
Performance Units and Performance Stock [Abstract]      
Compensation expense related to the company's stock-based compensation plans | $ 41,000,000 38,000,000 44,000,000
Gathering And Processing Costs [Member]      
Performance Units and Performance Stock [Abstract]      
Compensation expense related to the company's stock-based compensation plans | $ 1,000,000 1,000,000 1,000,000
Exploration Costs [Member]      
Performance Units and Performance Stock [Abstract]      
Compensation expense related to the company's stock-based compensation plans | $ 23,000,000 21,000,000 26,000,000
General And Administrative [Member]      
Performance Units and Performance Stock [Abstract]      
Compensation expense related to the company's stock-based compensation plans | $ $ 69,000,000 68,000,000 60,000,000
$ 34.00 to $ 59.99 | Stock Options and Sars [Member]      
Summary Information By Grant Price Range For Stock Options And SARs Outstanding And Exercisable At End Of Period [Line Items]      
Stock Options and SARs Outstanding 1,472,000    
Weighted Average Remaining Life for Outstanding Options and SARs 1 year    
Weighted Average Grant Price For Outstanding Options and SARs | $ / shares $ 49.63    
Stock Options and SARs Exercisable 1,472,000    
Weighted Average Remaining Life For Exercisable Units 1 year    
Weighted Average Grant Price For Exercisable Options and SARs | $ / shares $ 49.63    
60.00 to 84.99 | Stock Options and Sars [Member]      
Summary Information By Grant Price Range For Stock Options And SARs Outstanding And Exercisable At End Of Period [Line Items]      
Stock Options and SARs Outstanding 2,392,000    
Weighted Average Remaining Life for Outstanding Options and SARs 4 years    
Weighted Average Grant Price For Outstanding Options and SARs | $ / shares $ 75.67    
Stock Options and SARs Exercisable 1,623,000    
Weighted Average Remaining Life For Exercisable Units 3 years    
Weighted Average Grant Price For Exercisable Options and SARs | $ / shares $ 78.51    
85.00 to 95.99 | Stock Options and Sars [Member]      
Summary Information By Grant Price Range For Stock Options And SARs Outstanding And Exercisable At End Of Period [Line Items]      
Stock Options and SARs Outstanding 1,684,000    
Weighted Average Remaining Life for Outstanding Options and SARs 6 years    
Weighted Average Grant Price For Outstanding Options and SARs | $ / shares $ 94.82    
Stock Options and SARs Exercisable 421,000    
Weighted Average Remaining Life For Exercisable Units 5 years    
Weighted Average Grant Price For Exercisable Options and SARs | $ / shares $ 94.73    
96.00 to 99.99 | Stock Options and Sars [Member]      
Summary Information By Grant Price Range For Stock Options And SARs Outstanding And Exercisable At End Of Period [Line Items]      
Stock Options and SARs Outstanding 2,239,000    
Weighted Average Remaining Life for Outstanding Options and SARs 7 years    
Weighted Average Grant Price For Outstanding Options and SARs | $ / shares $ 96.32    
Stock Options and SARs Exercisable 21,000    
Weighted Average Remaining Life For Exercisable Units 3 years    
Weighted Average Grant Price For Exercisable Options and SARs | $ / shares $ 98.06    
100.00 to 116.99 | Stock Options and Sars [Member]      
Summary Information By Grant Price Range For Stock Options And SARs Outstanding And Exercisable At End Of Period [Line Items]      
Stock Options and SARs Outstanding 1,316,000    
Weighted Average Remaining Life for Outstanding Options and SARs 4 years    
Weighted Average Grant Price For Outstanding Options and SARs | $ / shares $ 102.03    
Stock Options and SARs Exercisable 973,000    
Weighted Average Remaining Life For Exercisable Units 3 years    
Weighted Average Grant Price For Exercisable Options and SARs | $ / shares $ 102.03    
Pension Plans [Member]      
Defined Benefit and Defined Contribution Plan Disclosure [Line Items]      
Total pension plan costs | $ $ 37,000,000 34,000,000 36,000,000
Company contributions to foreign pension plans | $ 1,000,000 1,000,000 $ 1,000,000
Benefit obligation | $ 10,000,000 8,000,000  
Fair value of foreign pension plan assets | $ 8,000,000 7,000,000  
Accrued benefit cost | $ $ (200,000) $ (300,000)  
[1] The total intrinsic value of stock options/SARs exercised during the years 2017, 2016 and 2015 was $95 million, $84 million and $60 million, respectively. The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.
[2] Based upon the difference between the closing market price of the Common Stock on the last trading day of the year and the grant price of in-the-money stock options and SARs.
[3] The total intrinsic value of restricted stock and restricted stock units outstanding at December 31, 2017, 2016 and 2015 was approximately $421 million, $401 million and $347 million, respectively.
[4] The total intrinsic value of restricted stock and restricted stock units released during the years ended December 31, 2017, 2016 and 2015 was $91 million, $124 million and $109 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released.
[5] The total intrinsic value of Performance Awards outstanding at December 31, 2017, 2016 and 2015 was approximately $54 million, $55 million and $29 million, respectively.
[6] Upon completion of the Performance Period for the Performance Awards granted in 2013 and 2012, a performance multiple of 200% was applied to each of the grants resulting in additional grants of Performance Awards in February 2017 and 2016.
[7] The total intrinsic value of Performance Awards released during the years ended December 31, 2017, 2016 and 2015 was approximately $24 million, $10 million and $0, respectively.